In case you missed it: June 27 to July 1
A look back at the week's news.
Not just abortion: How the demise of Roe v Wade may impact fertility care
As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.
Pharmacies limiting Plan B purchases after Roe v. Wade reversal
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
HHS secretary details department’s efforts to protect reproductive health care
“The impact was visible and real,” said Xavier Becerra, secretary of the US Department for Health and Human Services during a press conference Tuesday.
SOGH responds to Roe v Wade decision
The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More
